Founded in 2014, Enterprise Therapeutics, classified under reg no. 09022750 is an active company. Currently registered at Sussex Innovation Centre Science Park Square BN1 9SB, Brighton the company has been in the business for 10 years. Its financial year was closed on Tue, 31st Dec and its latest financial statement was filed on 2022-12-31.
There is a single director in the company at the moment - John F., appointed on 3 November 2016. In addition, a secretary was appointed - Philip B., appointed on 15 December 2016. As of 1 June 2024, there were 14 ex directors - Bart D., Johnathan R. and others listed below. There were no ex secretaries.
| Office Address | Sussex Innovation Centre Science Park Square |
| Office Address2 | Falmer |
| Town | Brighton |
| Post code | BN1 9SB |
| Country of origin | United Kingdom |
| Registration Number | 09022750 |
| Date of Incorporation | Fri, 2nd May 2014 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st December |
| Company age | 10 years old |
| Account next due date | Mon, 30th Sep 2024 (121 days left) |
| Account last made up date | Sat, 31st Dec 2022 |
| Next confirmation statement due date | Thu, 16th May 2024 (2024-05-16) |
| Last confirmation statement dated | Tue, 2nd May 2023 |
Position: Secretary
Appointed: 15 December 2016
Position: Director
Appointed: 03 November 2016
The register of persons with significant control who own or control the company is made up of 4 names. As we found, there is Enterprise Therapeutics Holdings Limited from Falmer, Brighton, United Kingdom. The abovementioned PSC is classified as "a corporate", has 75,01-100% voting rights and has 75,01-100% shares. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares. The second one in the persons with significant control register is Ip2Ipo Portfolio (Gp) Limited that entered London, United Kingdom as the address. This PSC has a legal form of "a corporate", owns 25-50% shares, has 25-50% voting rights. This PSC owns 25-50% shares and has 25-50% voting rights. The third one is Touchstone Innovations Businesses Llp, who also fulfils the Companies House conditions to be categorised as a person with significant control. This PSC has a legal form of "a corporate", owns 25-50% shares, has 25-50% voting rights. This PSC , owns 25-50% shares and has 25-50% voting rights.
Enterprise Therapeutics Holdings Limited
| Legal authority | Companies Act 2006 |
| Legal form | Corporate |
| Country registered | England And Wales |
| Place registered | Companies House |
| Registration number | 12868901 |
| Notified on | 5 October 2020 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Ip2ipo Portfolio (Gp) Limited
The Walbrook Building 25 Walbrook, London, EC4N 8AF, United Kingdom
| Legal authority | Companies Act 2006 |
| Legal form | Corporate |
| Country registered | United Kingdom |
| Place registered | Companies House |
| Registration number | 10360684 |
| Notified on | 7 February 2020 |
| Ceased on | 5 October 2020 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Touchstone Innovations Businesses Llp
52 Princes Gate, Exhibition Road, London, SW7 2PG, United Kingdom
| Legal authority | United Kingdom (England And Wales) |
| Legal form | Corporate |
| Country registered | England And Wales |
| Place registered | Companies House |
| Registration number | Oc333709 |
| Notified on | 6 April 2016 |
| Ceased on | 5 October 2020 |
| Nature of control: |
25-50% voting rights 25-50% shares |
Epidarex Capital Partners Limited
137a George Street, Edinburgh, Scotland, EH2 4JY, Scotland
| Legal authority | Scotland |
| Legal form | Corporate |
| Country registered | Scotland |
| Place registered | Companies House |
| Registration number | Sc437985 |
| Notified on | 6 April 2016 |
| Ceased on | 6 April 2018 |
| Nature of control: |
25-50% voting rights 25-50% shares |
| Profit & Loss | |||
|---|---|---|---|
| Accounts Information Date | 2019-12-31 | 2020-12-31 | 2021-12-31 |
| Balance Sheet | |||
| Current Assets | 5 032 633 | 7 018 901 | 3 220 540 |
| Net Assets Liabilities | 3 977 917 | 6 109 396 | 1 919 607 |
| Other | |||
| Accrued Liabilities | 529 546 | 627 439 | 543 374 |
| Accumulated Depreciation Impairment Property Plant Equipment | 32 820 | 14 797 | |
| Additions Other Than Through Business Combinations Property Plant Equipment | 1 284 | 1 465 | |
| Administrative Expenses | 10 466 219 | 7 211 710 | 5 374 614 |
| Amounts Owed To Related Parties | 5 712 | 33 286 | |
| Applicable Tax Rate | 0 | 0 | 0 |
| Average Number Employees During Period | 8 | 12 | 9 |
| Balances Amounts Owed By Related Parties | 3 049 157 | 40 | |
| Cash Cash Equivalents | 2 508 323 | 1 821 342 | 1 637 365 |
| Cash Cash Equivalents Cash Flow Value | 2 508 323 | 1 821 342 | 1 637 365 |
| Comprehensive Income Expense | -15 254 380 | -11 726 536 | -8 379 578 |
| Cost Sales | 1 069 549 | 1 238 939 | |
| Current Tax For Period | -1 928 706 | -1 328 615 | -1 168 091 |
| Depreciation Expense Property Plant Equipment | 10 141 | 8 399 | 5 602 |
| Further Item Payment To Acquire Or Redeem Own Shares Component Total Payments To Acquire Or Redeem Own Shares | 2 719 | 1 827 | |
| Further Item Tax Increase Decrease Component Adjusting Items | -571 684 | -868 997 | |
| Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | -153 399 | -152 326 | 386 526 |
| Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | -132 404 | -3 266 140 | 3 485 254 |
| Gain Loss On Disposals Property Plant Equipment | -765 | ||
| Government Grant Income | 157 138 | ||
| Gross Profit Loss | 8 063 | -13 526 | |
| Income Expense Recognised Directly In Equity | 2 | 7 994 750 | |
| Income Taxes Paid Refund Classified As Operating Activities | 1 259 037 | 1 921 500 | 1 328 615 |
| Income Tax Expense Credit | -1 928 707 | -1 328 615 | -1 199 485 |
| Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | -8 577 850 | -686 981 | -183 977 |
| Increase Decrease In Current Tax From Adjustment For Prior Periods | 906 | ||
| Increase From Depreciation Charge For Year Property Plant Equipment | 8 399 | 5 602 | |
| Interest Expense On Bank Overdrafts | 2 807 | 2 719 | 1 827 |
| Interest Paid Classified As Financing Activities | 2 807 | 2 719 | |
| Interest Paid Classified As Operating Activities | 2 807 | 2 719 | 1 827 |
| Interest Payable Similar Charges Finance Costs | 2 807 | 2 719 | 1 827 |
| Interest Received Classified As Investing Activities | 75 749 | 14 483 | 693 |
| Interest Received Classified As Operating Activities | 75 752 | 14 483 | 693 |
| Investments In Subsidiaries Joint Ventures Associates | 1 | 1 | |
| Issue Equity Instruments | 2 | 7 994 750 | |
| Net Cash Flows From Used In Financing Activities | -2 805 | 7 992 034 | -1 827 |
| Net Cash Flows From Used In Investing Activities | 70 422 | 13 199 | -772 |
| Net Cash Flows From Used In Operating Activities | -8 645 467 | -8 692 214 | -181 378 |
| Net Cash Generated From Operations | -10 613 714 | -1 509 993 | |
| Operating Profit Loss | -9 628 838 | -7 203 647 | -5 355 840 |
| Other Disposals Decrease In Depreciation Impairment Property Plant Equipment | 4 063 | 23 625 | |
| Other Disposals Property Plant Equipment | 4 063 | 24 390 | |
| Other Interest Income | 75 749 | 14 483 | 693 |
| Other Interest Receivable Similar Income Finance Income | 75 749 | 14 483 | 693 |
| Other Operating Expenses By Function | 157 138 | ||
| Other Operating Income | 837 381 | 157 138 | 32 300 |
| Other Payables | 8 870 | 8 823 | 6 116 |
| Other Remaining Operating Income | 32 300 | ||
| Other Taxation Social Security Payable | 44 473 | 48 285 | 286 112 |
| Payments To Acquire Own Shares | 5 256 | ||
| Pension Costs Defined Contribution Plan | 56 228 | 117 416 | 86 975 |
| Proceeds From Issuing Shares | 2 | 8 000 009 | |
| Profit Loss | -7 627 190 | -5 863 268 | -4 189 789 |
| Profit Loss Before Tax | -7 627 191 | -5 863 268 | -4 189 789 |
| Property Plant Equipment Gross Cost | 41 070 | 18 145 | |
| Property Plant Equipment Including Right-of-use Assets | 15 366 | 8 250 | 3 348 |
| Purchase Property Plant Equipment | 5 327 | 1 284 | 1 465 |
| Revenue From Sale Goods | 1 077 612 | 1 225 413 | |
| Social Security Costs | 144 480 | 191 623 | 164 469 |
| Staff Costs Employee Benefits Expense | 1 343 763 | 1 634 969 | 1 906 982 |
| Tax Expense Credit Applicable Tax Rate | -1 815 620 | -1 366 458 | -1 017 825 |
| Tax Increase Decrease From Effect Adjustment For Long Accounting Periods | 1 419 | 30 198 | 85 |
| Tax Increase Decrease From Effect Adjustment In Research Development Tax Credit | -114 505 | 714 777 | 363 229 |
| Tax Increase Decrease From Effect Foreign Tax Rates | 906 | ||
| Tax Increase Decrease From Effect Indexation Allowance On Capital Gains | 1 160 766 | ||
| Tax Increase Decrease From Other Tax Effects Tax Reconciliation | -135 448 | ||
| Total Assets | 5 047 999 | 7 027 152 | 3 223 889 |
| Trade Creditors Trade Payables | 487 193 | 227 497 | 435 394 |
| Trade Other Payables | 1 070 082 | 917 756 | 1 304 282 |
| Trade Other Receivables | 2 524 310 | 5 197 559 | 1 583 175 |
| Turnover Revenue | 1 077 612 | 1 225 413 | |
| Wages Salaries | 1 143 055 | 1 325 930 | 1 655 538 |
| Type | Category | Free download | |
|---|---|---|---|
| AA |
Full accounts data made up to 2022-12-31 filed on: 15th, June 2023 |
accounts | Free Download (25 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy